Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Hormonal Contraceptive market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Hormonal Contraceptive market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Oral Contraceptive Pills Injectable Birth Control Emergency Contraceptive Pills Vaginal Rings Transdermal Patches Segmented by End User/Segment Hospitals Household Clinics Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey The Female Health Company Teva Pharmaceutical Industries Pfizer Organon International Mylan N.V. Merck and Co Mayer Laboratories Johnson and Johnson Church and Dwight Co Bayer AG Ansell Limited Afaxys

List of Figures

Figure Hormonal Contraceptive Picture
Figure Global Hormonal Contraceptive Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Hormonal Contraceptive Sales Value CAGR (2020-2027) by Region
Figure Global Hormonal Contraceptive Sales Value Market Share by Company, 2020
Figure Product Picture of Oral Contraceptive Pills
Figure Product Picture of Injectable Birth Control
Figure Product Picture of Emergency Contraceptive Pills
Figure Product Picture of Vaginal Rings
Figure Product Picture of Transdermal Patches
Figure Global Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure North America Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure Europe Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure Asia Pacific Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure Central & South America Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure Middle East & Africa Hormonal Contraceptive Sales Value Market Share by Category, 2020
Figure Hormonal Contraceptive in Hospitals
Figure Global Hormonal Contraceptive Market: Hospitals (2016-2021)
Figure Hormonal Contraceptive in Household
Figure Global Hormonal Contraceptive Market: Household (2016-2021)
Figure Hormonal Contraceptive in Clinics
Figure Global Hormonal Contraceptive Market: Clinics (2016-2021)
Figure Global Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure North America Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure Europe Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Hormonal Contraceptive Sales Value Market Share by End User/Segment, 2020
Figure Global Hormonal Contraceptive Sales Value Market Share by Region (2016-2021)
Figure North America Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Europe Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure North America Hormonal Contraceptive Sales Value Market Share by Country, 2020
Figure United States Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Canada Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)
Figure Mexico Hormonal Contraceptive Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Hormonal Contraceptive Market Status and Forecast (2016-2027) 1.3.2 Global Hormonal Contraceptive Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Hormonal Contraceptive Supply by Company 2.1 Global Hormonal Contraceptive Sales Value by Company 2.2 Hormonal Contraceptive Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Hormonal Contraceptive Market Status by Category 3.1 Hormonal Contraceptive Category Introduction 3.1.1 Oral Contraceptive Pills 3.1.2 Injectable Birth Control 3.1.3 Emergency Contraceptive Pills 3.1.4 Vaginal Rings 3.1.5 Transdermal Patches 3.2 Global Hormonal Contraceptive Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Hormonal Contraceptive Market Status by End User/Segment 4.1 Hormonal Contraceptive Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Household 4.1.3 Clinics 4.2 Global Hormonal Contraceptive Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Hormonal Contraceptive Market Status by Region 5.1 Global Hormonal Contraceptive Market by Region 5.2 North America Hormonal Contraceptive Market Status 5.3 Europe Hormonal Contraceptive Market Status 5.4 Asia Pacific Hormonal Contraceptive Market Status 5.5 Central & South America Hormonal Contraceptive Market Status 5.6 Middle East & Africa Hormonal Contraceptive Market Status6 North America Hormonal Contraceptive Market Status 6.1 North America Hormonal Contraceptive Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Hormonal Contraceptive Market Status 7.1 Europe Hormonal Contraceptive Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Hormonal Contraceptive Market Status 8.1 Asia Pacific Hormonal Contraceptive Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Hormonal Contraceptive Market Status 9.1 Central & South America Hormonal Contraceptive Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Hormonal Contraceptive Market Status 10.1 Middle East & Africa Hormonal Contraceptive Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Hormonal Contraceptive Market Forecast by Category and by End User/Segment 12.1 Global Hormonal Contraceptive Sales Value Forecast (2022-2027) 12.2 Global Hormonal Contraceptive Forecast by Category 12.3 Global Hormonal Contraceptive Forecast by End User/Segment13 Global Hormonal Contraceptive Market Forecast by Region/Country 13.1 Global Hormonal Contraceptive Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 The Female Health Company 14.1.1 Company Information 14.1.2 Hormonal Contraceptive Product Introduction 14.1.3 The Female Health Company Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Teva Pharmaceutical Industries 14.2.1 Company Information 14.2.2 Hormonal Contraceptive Product Introduction 14.2.3 Teva Pharmaceutical Industries Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Pfizer 14.3.1 Company Information 14.3.2 Hormonal Contraceptive Product Introduction 14.3.3 Pfizer Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Organon International 14.4.1 Company Information 14.4.2 Hormonal Contraceptive Product Introduction 14.4.3 Organon International Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Mylan N.V. 14.5.1 Company Information 14.5.2 Hormonal Contraceptive Product Introduction 14.5.3 Mylan N.V. Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Merck and Co 14.6.1 Company Information 14.6.2 Hormonal Contraceptive Product Introduction 14.6.3 Merck and Co Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Mayer Laboratories 14.7.1 Company Information 14.7.2 Hormonal Contraceptive Product Introduction 14.7.3 Mayer Laboratories Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Johnson and Johnson 14.8.1 Company Information 14.8.2 Hormonal Contraceptive Product Introduction 14.8.3 Johnson and Johnson Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Church and Dwight Co 14.9.1 Company Information 14.9.2 Hormonal Contraceptive Product Introduction 14.9.3 Church and Dwight Co Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Bayer AG 14.10.1 Company Information 14.10.2 Hormonal Contraceptive Product Introduction 14.10.3 Bayer AG Hormonal Contraceptive Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 Ansell Limited 14.12 Afaxys15 Conclusion16 Methodology